You may also like
Fresenius Kabi USA Initiates Voluntary Recall of Single Lot of Magnesium Sulfate
FOR IMMEDIATE RELEASE - May 25, 2013 - Fresenius Kabi USA announced today it has initiated a voluntary recall of one lot – Lot 6103882 – of Magnesium Sulfate Injection, USP due to the potential presence of glass particles in the vials. The recall is a precautionary measure, following a routine company inspection of retained product samples.
Mortality Lower With Off-Pump Bypass in Patients With Atheromatous Aortic Disease
NEW YORK (Reuters Health) – For patients with coronary artery disease complicated by atheromatous aortic disease, the mortality is halved and neurologic […]
Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams
In this multicenter observational study, centers with shock teams were more likely to obtain invasive hemodynamics, use advanced types of MCS, and have lower risk-adjusted mortality. A standardized multidisciplinary shock team approach may improve outcomes in CS.
